Prebiotic intervention with HAMSAB in untreated essential hypertensive patients: a phase II randomized trial — ASN Events
  1. Schedule
  2. Concurrent Session - Human Microbiomes
  3. Prebiotic intervention with HAMSAB in untreated essential hypertensive patients: a phase II randomized trial

Prebiotic intervention with HAMSAB in untreated essential hypertensive patients: a phase II randomized trial (94039)

Hamdi Jama 1 , Dakota Rhys-Jones 1 , Michael Nakai 1 , CK Yao 1 , Rachel E Climie 2 , Yusuke Sata 3 , Dovile Anderson 4 , Darren J Creek 4 , Geoffrey A Head 3 , David M Kaye 3 , Charles R Mackay 1 , Jane Muir 1 , Francine Z Marques 1
  1. Monash University, Melbourne, VICTORIA, Australia
  2. Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia
  3. Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia
  4. Monash Institute of Pharmaceutical Sciences, , Monash University, Melbourne, Victoria, Australia
Publish consent withheld